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Consanguineous marriage is deeply embedded in the 
fabric of South-East Asian society. Maple Syrup Urine 
Disease (MSUD) and congential adrenal hyperplasia 
(CAH)  are autosomal recessive diseases, with an 
increased risk of transmission amongst progeny of 
consanguineous relationships. Maple syrup urine 
disease (MSUD) is an autosomal-recessive disorder of 
branched-chain amino acid (BCAA) metabolism, 
namely leucine, isoleucine and valine. It is rare in most 
populations occurring in about 1 in 185,000 live 
births.1 Deficiency of branched chain keto acid 
dehydrogenase(BCKD) results in accumulations of the 
aforementioned AAs, allo-isoleucine and alpha-
ketoisocaproic acid (aKIC), resulting in cerebral edema 
and encephalopathy.Classic sign is “Burnt Sugar” or 
“Maple Syrup” smell in urine due to Alpha-Hydroxy 
Acid . 2-4  MSUD is further divided into four types i.e. 
Classic , intermediate, intermittent  and thiamine 
responsive , based on age of onset, severity and 
residual BCKAD enzyme activity. Clinical 
manifestations of Classic MSUD are manifested in 
early neonatal life and range from Maple syrup odor 
in cerumen within 12 hours after birth; elevations of 
allo-leucine and branched chain AAs in plasma by 12-
24 hours; irritability, vomiting, poor feeding, and 
ketonuria and 2-3 days after birth; followed by 
neonatal encephalopathy: lethargy, apnea, 
opisthotonus, “Bicycling” and “Fencing” posturing by 
age four to five days. Respiratory failure ultimately 
sets in around days 7 to 10. If left untreated can result 
in developmental delay,cerebral palsy, seizures, and 
mortality. 5-10 
MSUD  like other Autosomal recessive disorders 
follows a pattern where there is a 25% chance of being 
affected, 25% chance of being spared and not a carrier, 
while 50% chance of being a carrier and unaffected.3 
Progeny born out of a consanguineous relationships or 
inbreeding have a higher risk of mortality, morbidity, 
congenital anomalies .Incidence of inborn error of 
metabolism carries a higher weightage in Pakistan, 
Turkey and Arab countries  compared to a Western 
country such as Denmark where consanguinity is 
rarely a norm. 7 Treatment consists of leucine 
restriction in diet, management of precipitating 
stressful states with judicious supplementation of 
valine and isoleucine.4 
CAH is an autosomal recessive disorder, characterized 
by deficiency of 21 α hydroxylase enzyme (90% of 
cases) and elevated levels of 17-OH Progesterone. This 
results in elevated levels of androgens causing 
virilization in females and diminished 
mineralocorticoids and cortisol.  Based on correction  
for age and birth weight threshold values of 17 OH-
Progesterone spectrum ranges from normal, possible 
CAH and probable CAH. 11-16 
 
Case Report: 
A 16 day old girl, born from a first-degree 
consanguineous marriage, as a second child, at term  
initially had no symptoms of any respiratory distress 
or irritability. She was easily taking breast feeds except 
delayed crying for 3 minutes immediately after birth 
and ambiguous genitalia. On the 4th day she 
developed marked difficulty in breathing, cyanosis 
and grunting, with repeated bouts of vomiting with 
inability to feed. Antenatal History was significant for 
Vacuum Assisted Delivery at term with 
polyhydramnion . There was a prior history of 
neonatal demise in the first sibling with unknown 
cause though it was suspected that she might be a case 
of undiagnosed MSUD as well after the second child 
was diagnosed. Parents also denied any genetic testing 
done after the death of their first born. Patient was 
referred to our hospital NICU for ventilator support 
by the private hospital, where her condition further 
deteriorated ,with a 6 days history of shortness of 
breath, odour of “burnt sugar” in urine, poor feeding 
and vomiting with episodes of tachypnea and 
grunting, cyanosis, seizures. Upon examination patient 
appeared pale, lethargic, and afebrile with bulging 
fontanel, thin extremities and normal anthropometry. 
Patient had a weight of 2500 grams, hypotonia, 
hyporeflexia appreciated in extremities, with bilateral 
basilar crackles and lower edge of liver and spleen 
palpable subcostally 4cm and 3cm respectively. 




Lab testing revealed marked urinary levels of 
branched chain amino acids (ILE 2360 umol/L, LEU 
447 umol/L) with serum levels suggesting 
hyperammonemia (123 umol/l). She had elevated 17 
OH-Progesterone on day 7th (47 nmol/l-possible 
CAH), with Lactate levels of 1.79 mmol/L and Serum 
TSH 1.5. Her condition further deteriorated with a 
raised anion gap acidosis of 17-Na+143, K+3.6, 
Cl+107.HCO3 19.Her BSR on admission to the NICU 
was 107 mg/dl a marked decrease in level from 253 
mg/dl from 5 days prior in the private hospital.Patient 
was placed on ventilator after resuscitation with 
inotropic support, given IV antibiotics, IV fluids, SpO2 
monitoring and vitals monitoring hourly. She showed 
no signs of improvement and died after a couple of 
days of Ventilator support. 
 
Discussion 
This report highlights a case of MSUD associated with 
elevated levels of 17 OH-Progesterone; product of a 
consanguineous marriage. This case demonstrates 
Classic MSUD presentations; with maple syrup urine 
odor, episodes of difficulty breathing, grunting, 
neonatal encephalopathy; seizures, vomiting, 
irritability, lethargy, inability to take regular feeds, 
vomiting, apnea later complicated with central 
respiratory failure. Due to elevated levels of 17 OH-
Progesterone (47.2 nmol/l) corrected for age and birth 
weight patient was a suspected case of another 
autosomal recessive “Possible” CAH.16 Lack of proper 
genetic counseling and Antenatal screening resulted in 
an inadequate management warranting better 
planning and implementation of genetic counseling 
and screening in high risk families. 
It is an established fact that consanguinity results in a 
higher prevalence of genetic anomalies.7 Discouraging 
against consanguineous marriage is in direct conflict 
with medical ethics and completely disregards cultural 
footing that this practice has in a country like Pakistan 
where consanguineous marriage is seen as a means to 
maintain Kinship and strong sociocultural bonds. 17 
However, emphasis should be laid on proper genetic 
counseling, evaluating relatives at risk  rooting out 
misconceptions on inheritance, identifying families at 
risk and screening should be instituted, none of which 
was implemented in this case as laid down by the 
National Society of Genetic Counselors. 4,18 Thus it was 
advised further to the parents of the child to undergo 
genetic testing and antenatal screening to be better 
prepared for future unwanted occurrences if any. 
MSUD and CAH like other autosomal recessive 
disease are seen in direct proportion consanguinity. 
More than one such disease is not usually seen in a 
single individual. Genetic counselling is highly desired 
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